Amgen AMGN
$460.42 +$0.14 (+0.03%)
Market closed · Nov 6, 9:50 pm ET · Last extended-hours $461.50 +0.23%
Open$448.17
Prev close$460.28
Day range$447.04 – $462.91
Volume2.58M
Market cap$249.05B
P/E (TTM)26.7
Dividend yield2.16%
AMGN Stock News
Headlines matching Amgen or the AMGN ticker, most recent first.
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
- Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
- Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $457
- Setback for the second time in a week! Novartis (NVS.US) sees its blockbuster heart disease drug fail in Phase III trials, causing a sharp drop in share price; Amgen (AMGN.US) suffers collateral damage. Negative
- Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
- Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
- William Blair Maintains Amgen(AMGN.US) With Buy Rating
- Amgen Advances Tarlatamab Shot Vs. Infusion in Phase 3 Lung Cancer Study
- Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $457 Positive
- A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $317 to $452
- Citi Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $405
- BMO Capital Downgrades Amgen(AMGN.US) to Hold Rating, Maintains Target Price $450 Negative
- Amgen | 3: Initial statement of beneficial ownership of securities- Dittrich Thomas J.W.
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $500
No comments yet — be the first to weigh in on AMGN.
Sign in to join the discussion.